- WELL has entered into a strategic alliance agreement with
Tali.ai which allows WELL to commercialize Tali's AI technology
across WELL's EMR portfolio. Tali's technology allows doctors to
have a 'conversation with their EMR' to support patients with
greater efficiency and deliver improved patient outcomes.
- WELL Health announces a minority investment through its WELL
Ventures subsidiary in Tali.ai, a Canadian leader in artificial
intelligence (AI) voice solutions for doctors and healthcare
providers
- Tali.ai is the latest application to be added to WELL's
apps.health marketplace for integrated EMR apps, providing more
than 15,000 doctors and other healthcare providers in over 2,800
clinics across Canada in WELL's
EMR network access to the cutting-edge technology.
VANCOUVER, BC, April 13,
2022 /CNW/ - WELL Health Technologies Corp.
(TSX: WELL) (the "Company" or "WELL"), a company
focused on positively impacting health outcomes by leveraging
technology to empower practitioners and their patients globally,
announces that its wholly owned subsidiary WELL Ventures has made a
significant minority investment in 11855760 Canada Inc.
("Tali.ai"), an AI-powered virtual assistant. Tali.ai
enables doctors and other healthcare providers to easily retrieve
essential information from their EMR software and issue voice
commands using Natural Language Processing (NLP) algorithms.
This means that a healthcare provider can vocally request
information or action from their EMR and Tali.ai will
search/present or action the request automatically.
"We are excited to closely collaborate with Tali.ai to create a
transformative healthcare productivity and efficiency tool.
Tali's technology allows doctors to have a voice conversation with
their EMR and quickly retrieve information at the point of care,"
said Hamed Shahbazi, Chairman and
CEO of WELL. "This investment is a continuation of WELL's
efforts to support doctors and be at the frontier of innovative
healthcare technology."
Tali.ai uses cutting edge NLP algorithms and AI-powered voice
capabilities to allow doctors and healthcare providers to retrieve
essential information, including medical and drug search, within
their EMR software, navigate and initiate key EMR tasks such as
prescriptions or labs, and automate the time-consuming task of
clinical documentation. Tali.ai's technology is voice
enabled, evidence-based, and compatible with any professional EMR
that provides for programmatic integration.
"We're thrilled to join the WELL ecosystem through this
investment and strategic partnership," said Mahshid Yassaei,
founder and CEO of Tali.ai. "WELL's position as the Canadian
leader in digital patient engagement aligns extremely well with our
mission to enhance and support the day-to-day tasks of doctors and
healthcare providers through technology solutions."
This partnership enhances both Tali.ai and WELL's overarching
mission to positively impact patient-first health outcomes by
leveraging pioneering technology to empower and support doctors and
other healthcare practitioners. WELL Ventures has a mandate
to invest in exceptional leaders, entrepreneurs and businesses
supporting the global digital health ecosystem, with an emphasis on
advancing innovative digital health initiatives in Canada.
WELL Ventures has a defined focus on all aspects of the digital
health ecosystem with a keen focus on practitioner enablement tools
and technologies.
Amir Javidan, WELL's Chief
Operating Officer commented, "Leveraging voice as a new modality
for interacting with the EMR can significantly magnify the output
and impact of practitioners. This is a very exciting addition to
WELL's practitioner enablement platform, in supporting both our own
outpatient medical clinics and for our network of EMR customers'
clinics."
An investment from WELL Ventures generally includes a strategic
alliance or collaboration agreement that provides portfolio
companies with access to WELL's own substantial technology and
healthcare assets; as such, WELL and Tali.ai have established a
five-year strategic alliance with the ability to cross license,
resell and commercialize Tali.ai AI's technology across WELL's EMR
portfolio. Tali.ai is the latest application to join WELL's
apps.health ecosystem which enables more than 15,000 healthcare
providers in over 2,800 clinics across Canada in WELL's EMR portfolio to connect and
access new and pioneering solutions, like Tali.ai, which integrate
securely and seamlessly into a clinic's EMR software.
WELL's app marketplace, apps.health, is a part of WELL's Digital
Health Apps business unit, which is focused on the development of
and investment in digital health applications. Its mission to
connect healthcare professionals with technology solutions in
digital health, allows technology companies and third-party
application developers to work with WELL to promote and accelerate
digital health innovation globally.
WELL has already started beta testing early versions of the
technology in WELL's own primary care clinics in British Columbia, Canada.
WELL HEALTH TECHNOLOGIES
CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies
Corp.
WELL is a technology enabled healthcare company whose
overarching objective is to positively impact health outcomes to
empower and support healthcare practitioners and their
patients. WELL has built an innovative practitioner
enablement platform that includes comprehensive end to end practice
management tools inclusive of virtual care and digital patient
engagement capabilities as well as Electronic Medical Records
(EMR), Revenue Cycle Management (RCM) and data protection
services. WELL uses this platform to power healthcare
practitioners both inside and outside of WELL's own omni-channel
patient services offerings. As such, WELL owns and operates
Canada's largest network of
outpatient medical clinics serving primary and specialized
healthcare services and is the provider of a leading
multi-national, multi-disciplinary telehealth offering. WELL
is publicly traded on the Toronto Stock Exchange under the symbol
"WELL" and is part of the TSX Composite Index. To
learn more about the Company, please visit: www.well.company.'
About Tali.ai:
A graduate of the Next AI program in Toronto, Tali.ai is a powerful AI-powered
virtual assistant for healthcare providers and information
retrieval engine. Tali.ai's technology allows for doctors to ask
their questions in natural language and get their answer back from
their Electronic Medical Record (EMR) software or other trusted
resource. Using cutting edge Natural Language Processing (NLP)
algorithms to save healthcare providers time, Tali.ai is on a
mission to give time back to the Doctor and empower them to deliver
better patient experiences and outcomes at the point of care. To
learn more about Tali.ai, please visit www.tali.ai
Forward-Looking
Information
This news release may contain "Forward-Looking Information"
within the meaning of applicable Canadian securities laws,
including, without limitation: information regarding
Tali.ai's successful addition to apps.health, and Tali.ai and
WELL's enhancements in positively impacting patient-first health
outcomes Forward-looking Information are based upon a number of
estimates and assumptions that, while considered reasonable by
management, are inherently subject to significant business,
economic and competitive uncertainties, and contingencies.
Forward-looking information generally can be identified by the use
of forward-looking words such as "may", "should", "will", "could",
"intend", "estimate", "plan", "anticipate", "expect", "believe" or
"continue", or the negative thereof or similar variations.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause future results,
performance or achievements to be materially different from the
estimated future results, performance or achievements expressed or
implied by those forward-looking statements and the forward-looking
statements are not guarantees of future performance. WELL's
statements expressed or implied by these forward-looking statements
are subject to a number of risks, uncertainties, and conditions,
many of which are outside of WELL 's control, and undue reliance
should not be placed on such statements. Forward-looking
statements are qualified in their entirety by inherent risks and
uncertainties, including: direct and indirect material adverse
effects from the COVID-19 pandemic; adverse market conditions;
risks inherent in the primary healthcare sector in general;
regulatory and legislative changes; that future results may vary
from historical results; inability to obtain any requisite future
financing on suitable terms; any inability to realize the expected
benefits and synergies of acquisitions; that market competition may
affect the business, results and financial condition of WELL and
other risk factors identified in documents filed by WELL under its
profile at www.sedar.com, including its most recent Annual
Information Form. Except as required by securities law, WELL
does not assume any obligation to update or revise any
forward-looking statements, whether as a result of new information,
events or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/well-health-makes-strategic-investment-in-taliai-to-develop-an-ai-powered-voice-assistant-for-practitioners-301524759.html
SOURCE WELL Health Technologies Corp.